Literature DB >> 19398605

Inflammatory mediators in Chinese patients with congestive heart failure.

Yongqing Wang1, Yanli Zhou, Ling Meng, Xinzheng Lu, Ning Ou, Xinli Li.   

Abstract

In this study, circulating levels of proinflammatory and anti-inflammatory mediators are studied in patients with chronic heart failure (CHF) in China. Sixty-five patients with CHF and 32 control subjects are studied. The proinflammatory and anti-inflammatory cytokines interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-alpha, atrial natriuretic peptide (ANP), and brain natriuretic peptide (BNP) in plasma are determined by immunoradiometric assay kits. Catecholamine (CA) in plasma is evaluated by high-performance liquid chromatography. Plasma levels of IL-6, IL-10, TNF-alpha, ANP, BNP, and CA in CHF patients are significantly higher than those in control subjects. Patients in a higher New York Heart Association (NYHA) class show higher concentrations of inflammatory mediators than those in a lower NYHA class, although the ratio of plasma IL-10 to TNF-alpha in patients with CHF is significantly lower than in the control group. It is concluded that proinflammatory and anti-inflammatory cytokine levels are increased and IL-10/TNF-alpha is decreased in Chinese patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398605     DOI: 10.1177/0091270009333265

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  9 in total

1.  A meta-analysis of proinflammatory cytokines in chronic heart failure.

Authors:  Mao Liu; Jian Chen; Dan Huang; Jianting Ke; Wei Wu
Journal:  Heart Asia       Date:  2014-09-06

2.  Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.

Authors:  Rocco Orlando; Sara De Martin; Laura Andrighetto; Maura Floreani; Pietro Palatini
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

3.  Plasma concentrations of adrenomedullin and natriuretic peptides in patients with essential hypertension.

Authors:  Wei Hu; Pang-Hu Zhou; Xiao-Bin Zhang; Chang-Geng Xu; Wei Wang
Journal:  Exp Ther Med       Date:  2015-03-11       Impact factor: 2.447

4.  Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.

Authors:  Rachael Deardorff; Francis G Spinale
Journal:  Biomark Med       Date:  2009-10-01       Impact factor: 2.851

5.  Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.

Authors:  Si-Dao Zheng; Hong-Jin Wu; Shao-Ping Yu; Jian-Xun Ren; Wei-Wei Duo; Zeng-Chun Ma; Yue Gao; Sheng-Qi Wang; Yu-Na Liu
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

6.  Inflammatory activation following interruption of long-term cardiac resynchronization therapy.

Authors:  Andrzej Rubaj; Piotr Ruciński; Krzysztof Oleszczak; Michał K Trojnar; Maciej Wójcik; Andrzej Wysokiński; Andrzej Kutarski
Journal:  Heart Vessels       Date:  2012-12-16       Impact factor: 2.037

7.  Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry.

Authors:  Michele Correale; Natale Daniele Brunetti; Antonio Totaro; Deodata Montrone; Anna Rita Russo; Anna Maria Fanigliulo; Riccardo Ieva; Matteo Di Biase
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Increased circulating obestatin in patients with chronic obstructive pulmonary disease.

Authors:  Yi Lei; Yasha Liang; Yifan Chen; Xiaojing Liu; Xiaoyang Liao; Fengming Luo
Journal:  Multidiscip Respir Med       Date:  2014-01-28

9.  Thymopentin improves cardiac function in older patients with chronic heart failure.

Authors:  Cao Xiaojing; Li Yanfang; Guo Yanqing; Cao Fangfang
Journal:  Anatol J Cardiol       Date:  2016-08-23       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.